Health Care & Life Sciences » Pharmaceuticals | J.B. Chemicals & Pharmaceuticals Ltd.

J.B. Chemicals & Pharmaceuticals Ltd. | Mutual Funds

Mutual Funds that own J.B. Chemicals & Pharmaceuticals Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin India Smaller Companies Fund
2,981,497
3.57%
0
1.37%
07/31/2018
DSP BlackRock Micro Cap Fund
2,289,433
2.74%
0
1.37%
02/28/2018
DSP BlackRock Tax Saver Fund
1,159,226
1.39%
1,003
0.84%
07/31/2018
ICICI Prudential Dynamic Plan
923,380
1.11%
0
0.27%
06/30/2018
DFA Dimensional Emerging Markets Value Fund
498,479
0.6%
-11,367
0.01%
01/31/2018
300,000
0.36%
-140,000
1.17%
08/31/2018
DFA Emerging Markets Core Equity Portfolio
262,964
0.32%
11,421
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
212,153
0.25%
0
0.01%
01/31/2018
Lacuna SICAV - Adamant Asia Pacific Health
200,000
0.24%
200,000
2.7%
12/31/2017
172,061
0.21%
0
0.38%
09/05/2018

About J.B. Chemicals & Pharmaceuticals

View Profile
Address
Neelam Centre, B Wing
Mumbai Maharashtra 400030
India
Employees -
Website http://www.jbcpl.com
Updated 07/08/2019
JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. It operates through the following business units: India; Russia & CIS; Global; Contrast Media; API; and Business Development. The India business unit produces medicine for gastro, cardiac, and pain management.